Clinical trial
Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia
NCT00462046 · Shanghai Jiao Tong University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00462046 |
|---|---|
| Title | Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia |
| Official title | The Efficacy and Safety of Berberine in the Treatment of Type 2 Diabetes With Dyslipidemia |
| Lead sponsor | Shanghai Jiao Tong University School of Medicine, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2, Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | Berberine |
| Enrollment | 120 |
| Start date | Apr 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Apr 18, 2007 |
| Last update posted | Apr 18, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: